Hemophilia management is evolving as several new therapies for the treatment of both Hemophilia A and Hemophilia B are being launched or studied in clinical trials. Capitalizing on our unique expertise in patient chart-based research we conducted the third wave of our syndicated survey, Q4 2017, based on real world data to monitor the impact of the new treatments for Hemophilia management.
Fill in the form below to access an overview of our Hemophilia A&B syndicated study including:
- Types of data collected
- Dates of research waves